Modafinil treatment of opioid-induced sedation (Q34215840)

31 July 2017

title

Modafinil treatment of opioid-induced sedation (English)

1 reference

31 July 2017

0 references

1 reference

Lynn Webster

1

1 reference

31 July 2017

Megan Andrews

series ordinal

2

1 reference

31 July 2017

Gregory Stoddard

series ordinal

3

1 reference

31 July 2017

publication date

1 June 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

4

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

135-140

1 reference

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03014.X

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03014.X

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03014.X

Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03014.X

Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03014.X

Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4637.2003.03014.X

10.1046/J.1526-4637.2003.03014.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference